Skip to main content
NewslettersWatchlist

Entourage Health Corp(ENTG-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.005
Day High0.010
Open:0.010
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Entourage Health to Host Third Quarter 2024 Earnings Conference Call
GlobeNewswire
Entourage Health Provides Company Update
AI-generated - The Globe and Mail
Entourage Health: Top 10 Undervalued Drug Manufacturers Industry Stocks (ENTG)
GlobeNewswire
Entourage Health Increases Senior Secured Credit Facility
GlobeNewswire
Entourage Health Provides Company Update
AI-generated - The Globe and Mail
Entourage Health: Top 10 Undervalued Drug Manufacturers Industry Stocks (ENTG)
AI-generated - The Globe and Mail
Entourage Health: Top 25 Undervalued TSX Venture Exchange Stocks (ENTG)
GlobeNewswire
Entourage Health Reports Second Quarter 2024 Financial Results
GlobeNewswire
Entourage Health to Host Second Quarter 2024 Financial Results Call
AI-generated - The Globe and Mail
Entourage Health: Top 10 Undervalued Drug Manufacturers Industry Stocks (ENTG)
GlobeNewswire
Entourage Announces Results of 2024 Annual General Meeting of Shareholders
GlobeNewswire
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
AI-generated - The Globe and Mail
Entourage Health: Top 10 Undervalued Growth Stocks on TSX-V (ENTG)
GlobeNewswire
Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28
GlobeNewswire
Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®
GlobeNewswire
Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
GlobeNewswire
Entourage Health to Report Fiscal Year 2023 Financial Results
AI-generated - The Globe and Mail
Entourage Health: Top 10 Undervalued Drug Manufacturers Industry Stocks (ENTG)
AI-generated - The Globe and Mail
Entourage Health: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ENTG)
GlobeNewswire
Entourage Health Provides Corporate Update
GlobeNewswire
Entourage Health Reports Third Quarter 2023 Financial Results and Posts $12.2 Million in Total Revenue
AI-generated - The Globe and Mail
Entourage Health: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ENTG)

Profile

Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution. The company operates in one segment, the production and sale of cannabis in Canada.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.